Lexaria Bioscience Corp (LEXX)
2.28
+0.04
(+1.79%)
USD |
NASDAQ |
Apr 23, 10:48
Lexaria Bioscience Gross Profit (Quarterly): 0.145M for Feb. 29, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 0.145M |
November 30, 2023 | 0.1465M |
August 31, 2023 | -0.0034M |
May 31, 2023 | 0.0804M |
February 28, 2023 | 0.0171M |
November 30, 2022 | 0.0819M |
August 31, 2022 | 0.0699M |
May 31, 2022 | 0.0811M |
February 28, 2022 | 0.0243M |
November 30, 2021 | 0.0083M |
August 31, 2021 | 0.0107M |
May 31, 2021 | 0.1441M |
February 28, 2021 | 0.1614M |
November 30, 2020 | 0.2312M |
August 31, 2020 | 0.0509M |
May 31, 2020 | 0.0161M |
February 29, 2020 | -0.0206M |
November 30, 2019 | 0.0025M |
August 31, 2019 | 0.1102M |
May 31, 2019 | 0.0568M |
February 28, 2019 | 0.0127M |
November 30, 2018 | 0.0201M |
August 31, 2018 | 0.0934M |
May 31, 2018 | 0.1379M |
February 28, 2018 | 0.1582M |
Date | Value |
---|---|
November 30, 2017 | 0.0185M |
August 31, 2017 | 0.0078M |
May 31, 2017 | 0.0201M |
February 28, 2017 | -0.0023M |
November 30, 2016 | 0.0083M |
August 31, 2016 | 0.0059M |
May 31, 2016 | -0.0031M |
February 29, 2016 | -0.0041M |
November 30, 2015 | -0.0036M |
August 31, 2015 | -0.0135M |
May 31, 2015 | -0.0025M |
February 28, 2015 | 0.0008M |
November 30, 2014 | |
July 31, 2014 | 0.0538M |
April 30, 2014 | 0.0575M |
January 31, 2014 | 0.0334M |
October 31, 2013 | -0.2928M |
July 31, 2013 | 0.0762M |
April 30, 2013 | 0.0883M |
January 31, 2013 | 0.1283M |
October 31, 2012 | 0.2035M |
July 31, 2012 | 0.2651M |
April 30, 2012 | 0.0017M |
January 31, 2012 | 0.1042M |
October 31, 2011 | 0.1647M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.0206M
Minimum
Feb 2020
0.2312M
Maximum
Nov 2020
0.0707M
Average
0.0634M
Median
Gross Profit (Quarterly) Benchmarks
Aurinia Pharmaceuticals Inc | 39.70M |
Sunshine Biopharma Inc | 2.568M |
Acasti Pharma Inc | -- |
Edesa Biotech Inc | -- |
Xenon Pharmaceuticals Inc | -- |